In the drug-free subgroup examined for this study the depression scores measured according to HAMD-17 during IFN-α therapy also increased significantly, and a return to baseline depression scores after the end of IFN-α therapy was observed. This evidence concerns the gene IFNA1 and major depressive disorder.